The Last Days Of NDAs: Uncertainties Remain Ahead Of 23 March Move From Drugs To Biologics

 
• By Sue Sutter
  
A row of yellow rubber ducks with one of the ducks facing in a different direction all the other duck are facing. The focus is on the duck facing in a different direction.
Despite 10 years to prepare for the transition, some questions remain a week before the deadline. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics